{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T16:18:32Z","timestamp":1696954712630},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,1,28]],"date-time":"2005-01-28T00:00:00Z","timestamp":1106870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:p><jats:bold>Abstract\u2002<\/jats:bold> A point prevalence study of prescription dosage was made among psychiatric inpatients in Japan with the following aims: (i) to analyze whether total chlorpromazine equivalent dose was related to patient characteristics or hospital and physician characteristics; and (ii) to analyze whether the usage of the two major categories of antipsychotics, butyrophenone and phenothiazine, were related to their expected pharmacological reactions. A comprehensive database of prescription contents and characteristics of patients, physicians and hospitals was developed from a survey of 1674 patients in 18 psychiatric hospitals. Using the tree\u2010based model analysis, factors related to the total chlorpromazine equivalent dose were analyzed. Factors included hospital ownership, staffing levels, physician specialty and patient length of stay, symptoms etc. The same analysis was then done for the two major categories of antipsychotics, in order to evaluate whether their expected pharmacological reactions were related to their usage. Factors related to the total chlorpromazine equivalent dose were age of patient, presence of hallucination, age of first psychiatric hospitalization, and change(s) in attending physician (while hospitalized). For the chlorpromazine equivalent dose of the butyrophenone category, the clinical factors related were abnormality in thought and hallucination, and for the phenothiazine category, it was bizarre behavior. Total chlorpromazine equivalent doses had no relationship with hospital or physician characteristics, and appeared to be determined by patient age and psychiatric symptoms. Doses in the butyrophenone category were related to pathological experiences and that in the phenothiazine category to behavioral aspects.<\/jats:p>","DOI":"10.1111\/j.1440-1819.2005.01334.x","type":"journal-article","created":{"date-parts":[[2005,1,28]],"date-time":"2005-01-28T15:13:33Z","timestamp":1106925213000},"page":"70-76","source":"Crossref","is-referenced-by-count":1,"title":["Factors related to prescription dosage in Japanese psychiatric hospitals"],"prefix":"10.1111","volume":"59","author":[{"given":"SHIGEKI","family":"NAWATA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEITA","family":"YAMAUCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NAOKI","family":"IKEGAMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,1,28]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0701"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200109000-00003"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1995.tb05791.x"},{"key":"e_1_2_6_5_2","first-page":"149","article-title":"Psychotropic polypharmacy in Japan: its present status and controversy on its merits and\/or demerits","volume":"5","author":"Itoh H","year":"1983","journal-title":"Shinkei Seishin Yakuri"},{"key":"e_1_2_6_6_2","first-page":"1181","article-title":"Problems of long\u2010term megadoses: polypharmacy and its side effects in psychopharmacotherapy","volume":"39","author":"Kazamatsuri H","year":"1997","journal-title":"Seishin Igaku"},{"key":"e_1_2_6_7_2","first-page":"51","article-title":"A survey of drug utilization in psychiatric hospitals in Japan: the basic analysis of the current status of prescription patterns","volume":"1","author":"Yamauchi K","year":"1998","journal-title":"Seishin Shinkeigaku Zassi"},{"key":"e_1_2_6_8_2","first-page":"640","article-title":"A survey of drug utilization in psychiatric hospitals in Japan: comparison of 1973, 1979 and 1993","volume":"102","author":"Yamauchi K","year":"2000","journal-title":"Seishin Shinkeigaku Zassi"},{"key":"e_1_2_6_9_2","volume-title":"Survey of Medical Care Institutions.","author":"MHW.","year":"1993"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/34.5.628"},{"key":"e_1_2_6_11_2","first-page":"60","article-title":"Antipsyhchotics","author":"Toru M","year":"1995","journal-title":"Rinsho Seishin Igaku"},{"key":"e_1_2_6_12_2","first-page":"41","volume-title":"Technique for the Psychiatric Treatment with Depot Medications","author":"Fujii Y","year":"1995"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1963.10500855"},{"key":"e_1_2_6_14_2","volume-title":"Classification and Regression Trees.","author":"Breiman L","year":"1984"},{"key":"e_1_2_6_15_2","first-page":"255","article-title":"General theory and application of the tree\u2010based model analysis to health care research","volume":"33","author":"Yamauchi K","year":"1996","journal-title":"Byouin Kanri"},{"key":"e_1_2_6_16_2","first-page":"377","volume-title":"Statistical Models in S.","author":"Clark LA","year":"1992"},{"key":"e_1_2_6_17_2","first-page":"1","article-title":"The therapeutic value of combinations of psychotropic drugs: a review","volume":"4","author":"Freeman H","year":"1967","journal-title":"Psychopharmacol. Bull."},{"key":"e_1_2_6_18_2","first-page":"433","article-title":"Polypharmacy: which drug combinations make sense?","volume":"33","author":"Hollister LE","year":"1982","journal-title":"Hospital Community Psychiatry"},{"key":"e_1_2_6_19_2","first-page":"1389","article-title":"A review of studies on reducing high doses and the number of antipsychotic drugs in chronic schizophrenia","volume":"4","author":"Uchida H","year":"2001","journal-title":"Rinsho Seisin Yakuri"},{"key":"e_1_2_6_20_2","first-page":"1423","article-title":"Guideline for revising high\u2010dose antipsychotic polypharmacy","volume":"4","author":"Suzuki T","year":"2001","journal-title":"Rinsho Seisin Yakuri"},{"key":"e_1_2_6_21_2","first-page":"1371","article-title":"Making the change from psychiatric polypharmacy to the newer antipsychotic medication","volume":"4","author":"Fujii Y","year":"2001","journal-title":"Rinsho Seisin Yakuri"},{"key":"e_1_2_6_22_2","first-page":"25","article-title":"A follow\u2010up study of schizophrenic patients discharged from neuro\u2010psychiatry clinic in medical school and the mental hospital","volume":"18","author":"Iwai H","year":"1976","journal-title":"Seishin Igaku"},{"key":"e_1_2_6_23_2","first-page":"343","article-title":"Aftercare of schizophrenic patients: pharmacotherapy and consistency of therapists","volume":"34","author":"Van der Kolk BA","year":"1983","journal-title":"Hospital Community Psychiatry"},{"key":"e_1_2_6_24_2","volume-title":"Patient Survey","author":"MHW.","year":"1993"},{"key":"e_1_2_6_25_2","volume-title":"Research on East Asia Psychotropics Prescription Pattern (REAP).","author":"Japan Society for the Promotion of Science.","year":"2002"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a006928"},{"key":"e_1_2_6_27_2","volume-title":"Survey of Medical Care Institutions.","author":"MHLW.","year":"2001"},{"key":"e_1_2_6_28_2","volume-title":"Mental Health and Welfare in Japan (Handbook of Mental Health and Welfare).","author":"Society for the Mental Health and Welfare.","year":"2001"}],"container-title":["Psychiatry and Clinical Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1819.2005.01334.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1819.2005.01334.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T17:09:53Z","timestamp":1696871393000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1819.2005.01334.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,28]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1111\/j.1440-1819.2005.01334.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1819.2005.01334.x","archive":["Portico"],"relation":{},"ISSN":["1323-1316","1440-1819"],"issn-type":[{"value":"1323-1316","type":"print"},{"value":"1440-1819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,28]]}}}